Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Marion Rabé"'
Autor:
Marion Rabé, Lucie Fonteneau, Lisa Oliver, Alvaro Morales-Molina, Camille Jubelin, Javier Garcia-Castro, Dominique Heymann, Catherine Gratas, François M. Vallette
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
We have observed a drug-tolerant/persister state in a human glioblastoma (GBM) cell line after exposure to temozolomide, the standard-of-care chemotherapeutic agent for GBM. We used a multicolor lentiviral genetic barcode labeling to follow cell popu
Externí odkaz:
https://doaj.org/article/af10a72ecb07478da8fef7c1d545335e
Autor:
Claire Pecqueur, Sébastien Faraj, Lisa Oliver, Julien Fleurence, Pierre Marquet, Meriem Bahri, Stéphane Birklé, Marion Rabé, Fanny Geraldo, François Paris, François M. Vallette, Sophie Fougeray, Joëlle Veziers, Catherine Gratas, Emilie Pinault, Sarah Vermeulen
Publikováno v:
International Journal of Cancer. 146:424-438
Stem cell chemo-resistance is still challenging the efficacy of the front-line temozolomide against glioblastoma. Novel therapies are urgently needed to fight those cells in order to control tumor relapse. Here, we report that anti-O-acetyl-GD2 adjuv
Publikováno v:
Biochemical and Biophysical Research Communications
Biochemical and Biophysical Research Communications, Elsevier, 2017, 493 (4), pp.1377-1383. ⟨10.1016/j.bbrc.2017.09.162⟩
Biochemical and Biophysical Research Communications, Elsevier, 2017, 493 (4), pp.1377-1383. 〈10.1016/j.bbrc.2017.09.162〉
Biochemical and Biophysical Research Communications, 2017, 493 (4), pp.1377-1383. ⟨10.1016/j.bbrc.2017.09.162⟩
Biochemical and Biophysical Research Communications, Elsevier, 2017, 493 (4), pp.1377-1383. ⟨10.1016/j.bbrc.2017.09.162⟩
Biochemical and Biophysical Research Communications, Elsevier, 2017, 493 (4), pp.1377-1383. 〈10.1016/j.bbrc.2017.09.162〉
Biochemical and Biophysical Research Communications, 2017, 493 (4), pp.1377-1383. ⟨10.1016/j.bbrc.2017.09.162⟩
International audience; Temozolomide (TMZ) is the main chemotherapeutic agent used for treating newly diagnosed Glioblas-toma Multiforme (GBM), the most frequent malignant brain tumors in adults. This alkylating agent induces DNA double strand breaks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b46256f1d11eb891f1c875f8933f5a
https://www.hal.inserm.fr/inserm-01813093/file/1-s2.0-S0006291X17319526-main_2018Eq9.pdf
https://www.hal.inserm.fr/inserm-01813093/file/1-s2.0-S0006291X17319526-main_2018Eq9.pdf
Publikováno v:
Oncotarget
ResearcherID
ResearcherID
// Catherine Gratas 1,2,3 , Quentin Sery 1,2,4 , Marion Rabe 1,2 , Lisa Oliver 1,2,3 and Francois M. Vallette 1,2,4 1. Centre de Recherche en Cancerologie Nantes Angers, UMR INSERM 892 / CNRS 6299 2. Universite de Nantes, Nantes F-44000, France 3. CH
Autor:
François M. Vallette, Catherine Gratas, Christelle Thibault-Carpentier, Marion Rabé, Hicham Janati, Solenne Dumont, Jean Clairambault
Publikováno v:
Cancer Research. 77:92-92
Glioblastoma multiforme (GBM) are the most aggressive and common brain tumors in adults. Despite surgery and combined radio-chemotherapy with temozolomide (TMZ), tumor reccurence always occurs. The median survival time for patients diagnosed with GBM
Autor:
Sigurd Bjarghov, Markus Loschenbrand, A. U. N. Ibn Saif, Raquel Alonso Pedrero, Christian Pfeiffer, Shafiuzzaman K. Khadem, Marion Rabelhofer, Frida Revheim, Hossein Farahmand
Publikováno v:
IEEE Access, Vol 9, Pp 58910-58943 (2021)
In recent years, power systems have undergone changes in technology and definition of the associated stakeholders. With the increase in distributed renewable generation and small- to medium-sized consumers starting to actively participate on the supp
Externí odkaz:
https://doaj.org/article/e2d138f4eb0d4b29b432808917831a61